Scientists hunt for better ways to diagnose and treat rare bone tumors
NCT ID NCT07315542
First seen Jan 05, 2026 · Last updated May 02, 2026 · Updated 17 times
Summary
This study looks at 300 people with cartilage tumors, including a type of bone cancer called chondrosarcoma. Researchers are studying genetic changes and molecules called microRNAs to better tell benign from malignant tumors and find new treatment targets. The goal is to improve diagnosis and create personalized therapies for hard-to-treat cases.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHONDROSARCOMAS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
First Department of Orthopaedic Surgery, St. Anne's University Hospital and Faculty of Medicine, Masaryk University, Brno, Czechia
RECRUITINGBrno, South Moravian, 60200, Czechia
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.